GSK3B and neurodegenerative disease: Following an analysis of prediction results, we selected CDK5 and GSK-3β as potential target candidates for the investigated polyphenols, both kinases being involved in the physiopathology of neurodegenerative diseases and neuropathic pain [20,21].